Skip to content

Merck cuts price of efavirenz for developing countries again

Cannabis may be safe and effective for HIV-related neuropathic pain

One in eight UK HIV clinicians say cost reduced ARV prescribing choices in 2006

Metabolic syndrome as common in HIV-negative as in HIV-positive individuals

Posaconazole successful in treating fluconazole- and itraconazole-resistant candidiasis

Once-daily nevirapine has more side-effects than twice-daily dose, needs more study

WHO Director-General: Thailand within its rights to issue compulsory licenses for HIV drugs

Swedish biotech licenses HIV drug to China for development

Abbott offers price cut to thwart Thai compulsory license on Kaletra